Johnson & Johnson
J&J accepts $4 bn bid from Carlyle for its ortho-clinical diagnostics business
01 Apr 2014
Johnson & Johnson's ortho-clinical diagnostics unit was created in 1994 when it acquired the clinical diagnostics division of Eastman Kodak and formed Johnson & Johnson Clinical Diagnostics, which was then merged in 1997 with Ortho Diagnostic Systems
J&J to sell Ortho Clinical Diagnostics unit to Carlyle for $4.15 bn
17 Jan 2014
US healthcare major Johnson & Johnson (J&J) yesterday agreed to sell its Ortho Clinical Diagnostics (OCD) unit to private equity firm Carlyle Group for $4.15 billion.
Mis-selling of drugs to cost J&J $2.2 bn in US settlement
05 Nov 2013
The cases, which date from the late 1990s through the early 2000s, involve alleged kickbacks to doctors and pharmacies to promote the antipsychotic drugs Risperdal and Invega, and heart drug Natrecor
PE firms in race for J&J’s Ortho Clinical Diagnostics unit
01 Oct 2013
Private equity firms have tabled preliminary bids for Johnson & Johnson's Ortho Clinical Diagnostics unit, which could fetch the US healthcare major around $5 billion
